ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$284.79
-1.60 (-0.56%)
▼
5d:
-1.54%
30d:
-11.0%
90d:
-18.6%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 28, 2026
28d
Smart Money Accumulation
ELV is down 6.7% this week, but smart money is accumulating calls. Top strike: $370 2026-04-17 with 320 OI. Call ratio: 64% View Scanner →
Strength: 4.7/10
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ELV appears deeply undervalued. Market expects -6.5% annual earnings decline despite 36% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: ELV appears deeply undervalued. Market expects -6.5% annual earnings decline despite 36% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$527.99
Based on 8.6% avg growth
INTRINSIC VALUE TODAY
$327.84
13.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $284.79, which is considered slightly low relative to its 30-day fair value range of $282.08 to $326.11. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.7) compared to its historical average (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 6.5% over the next few years. This pessimistic expectation contrasts with the company's recent 36.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ELV is in a downtrend. The price is currently testing key support at $282.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $380.95 (+33.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELV is in a downtrend. The price is currently testing key support at $282.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $380.95 (+33.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$282.08 -
$326.11
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.0% below Wall St target ($380.95)
Fair Price Analysis
30-Day Fair Range
$282.08 -
$326.11
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$282.46
Resistance Level
$301.00
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.73
Wall Street Target
$380.95
(+33.0%)
Revenue Growth (YoY)
9.5%
Earnings Growth (YoY)
36.3%
Profit Margin
2.8%
Valuation Discount vs History
-6.5% cheaper
PE vs Historical
9.7 vs 11.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.5%
(market-implied from PE analysis)
1-Year Target
$267.77
(-7%)
2-Year Target
$250.37
(-13%)
3-Year Target
$234.10
(-18%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$286.34
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 13.2%)
$957.60
(+234%)
Base:
(SPY PE: 9.7, Growth: 13.2%)
$415.90
(+45%)
Bear:
(PE: 8.3, Growth: 13.2%)
$353.52
(+23%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.56 | Current EPS (TTM): $25.21
Bull Case
$374.46
(+30%)
Analyst growth 16.8%, PE expands to 12.7
Base Case
$340.41
(+18%)
Market implied 16.8%, PE stable at 11.6
Bear Case
$198.21
(-32%)
Severe decline -20.0%, PE contracts to 9.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.7 to 11.9
Stabilization Target:
$350.31
(+22.3%)
PE Expansion Potential:
+22.3%
Share & Embed Analysis
Last updated: March 30, 2026 4:23 PM ET
Data refreshes hourly during market hours. Next update: 5:23 PM
Data refreshes hourly during market hours. Next update: 5:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-02-17
Ro Khanna
SELL
2026-01-29
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$97 | 57 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$339 | 59 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$361 | 49 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$212 | 61 BUY |
|
CNC
Centene Corp |
BUY
19 analysts |
$43 | 45 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
